A detailed history of Bank Of America Corp transactions in Immunome Inc. stock. As of the latest transaction made, Bank Of America Corp holds 239,582 shares of IMNM stock, worth $3.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
239,582
Previous 9,367 2457.72%
Holding current value
$3.05 Million
Previous $231,000 1154.55%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$11.54 - $22.11 $2.66 Million - $5.09 Million
230,215 Added 2457.72%
239,582 $2.9 Million
Q1 2024

May 15, 2024

SELL
$11.01 - $27.34 $173,495 - $430,823
-15,758 Reduced 62.72%
9,367 $231,000
Q4 2023

Feb 14, 2024

BUY
$7.3 - $10.73 $183,412 - $269,591
25,125 New
25,125 $268,000
Q4 2022

Feb 10, 2023

BUY
$2.21 - $5.0 $24 - $55
11 New
11 $0
Q1 2022

May 16, 2022

SELL
$3.88 - $13.99 $24,226 - $87,353
-6,244 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$12.96 - $23.44 $80,922 - $146,359
6,244 New
6,244 $81,000

Others Institutions Holding IMNM

About Immunome Inc.


  • Ticker IMNM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,127,400
  • Market Cap $154M
  • Description
  • Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...
More about IMNM
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.